Clinical Trial
Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response
- PMID: 4448555
Item in Clipboard
Clinical Trial
Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response
Int J Clin Pharmacol.
1974 Sep.
No abstract available
Similar articles
-
Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.N Engl J Med. 1970 Mar 5;282(10):521-7. doi: 10.1056/NEJM197003052821001. N Engl J Med. 1970. PMID: 4391708 No abstract available.
-
Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.Acta Med Scand Suppl. 1973;550:1-40. Acta Med Scand Suppl. 1973. PMID: 4201751 Clinical Trial. No abstract available.
-
[Mechanism of the antihypertensive action of propranolol].Minerva Cardioangiol. 1973 Apr;21(4):284-97. Minerva Cardioangiol. 1973. PMID: 4710125 Italian. No abstract available.
-
Propranolol.Dis Mon. 1974 Oct:1-31. doi: 10.1016/s0011-5029(74)80002-7. Dis Mon. 1974. PMID: 4606956 Review. No abstract available.
-
Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.Postgrad Med J. 1983;59 Suppl 3(689):140-58. Postgrad Med J. 1983. PMID: 6139800 Free PMC article. Review.
Cited by
-
Pharmacokinetics of atenolol in patients with renal impairment.Eur J Clin Pharmacol. 1977 Nov 14;12(3):175-80. doi: 10.1007/BF00609856. Eur J Clin Pharmacol. 1977. PMID: 590303
-
Concentration-effect analysis of antihypertensive drug response. Focus on calcium antagonists.Clin Pharmacokinet. 1994 Jun;26(6):472-85. doi: 10.2165/00003088-199426060-00005. Clin Pharmacokinet. 1994. PMID: 8070220 Review.
-
Pharmacokinetic-pharmacodynamic modeling of the antihypertensive effect of eprosartan in Black and White hypertensive patients.Clin Pharmacokinet. 2013 Sep;52(9):793-803. doi: 10.1007/s40262-013-0073-6. Clin Pharmacokinet. 2013. PMID: 23696281 Clinical Trial.
-
Clinical pharmacokinetics of beta-adrenoreceptors blockers.Drugs. 1976;11 SUPPL 1:111-21. doi: 10.2165/00003495-197600111-00026. Drugs. 1976. PMID: 6243
-
Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.Eur J Clin Pharmacol. 1977 Apr 20;11(4):239-45. doi: 10.1007/BF00607671. Eur J Clin Pharmacol. 1977. PMID: 324771 Clinical Trial. No abstract available.